Olaplex Holdings OLPX Q1 2026 Earnings Beat Revenue NA EPS 002 GPAct III GPAT Gained 157 Can It Break 1153 20260520 xAI Faces Employee Payment Delays for Tax Return Data Used in Grok Training Anthropic Could Reach 109 Billion Revenue in Q2 Marking First Profitable Quarter Source JPMorgan Boosts Price Target on Essex Property Trust ESS Amid Strong Apartment Demand Kraken Introduces Bitcoin Vault Offering Yield Opportunity for Crypto Investors Bloom Energy Shares Maintain Upward Trajectory Key Drivers Behind the Move US April Payrolls Surge Beyond Forecasts Yet Report Reveals Economic Concerns Dollar Declines on Growing Prospects of USIran Agreement PFFs 14 Billion Preferred Stock Strategy Over 60 in BankIssued Preferreds with Call Provisions That May Limit Upside Potential MTD Q1 2026 Earnings EPS Surpasses Consensus by 137 KTCC Q1 2026 Earnings Loss Per Share of 026 as Stock Declines 17 CMPX Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Surges 725 LRN Q1 2026 Earnings EPS Beat of 289 Drives Modest Stock Gains XPeng Q4 2025 Earnings EPS Surges to Profitability Stock Jumps 6 ODYS Q1 2026 Earnings WiderThanExpected Loss Pressures Shares LPL Financial Holdings LPLA Slides 48 as Broader Market Pressure Weighs on Financials PSF Edges Higher Cohen Steers Select Preferred and Income Fund Inc Shows Resilient Trading Indigo Acquisition Corp Unit INACU Holds Steady at 1028 as SPAC Units Trade in Tight Range BOK Financial Corporation BOKF Nudges Higher Testing Resistance Near 139 Oriental Culture Holding OCG Bounces From Support Eyes Resistance at 192 RWAYI Q1 2026 Earnings EPS Misses Estimates as Portfolio Adjustments Pressure Results XBP Q1 2026 Earnings Massive EPS Miss Overshadowed by Stock Rally Adagene Inc Q2 2025 Earnings EPS Miss Amid Continued RD Investment NCMI Q1 2026 Earnings EPS Miss Exceeds Estimates Stock Edges Higher Consensus Cloud Solutions Inc CCSI Q1 2026 Earnings Solid EPS Beat Lifts Sentiment Despite Flat Revenue Picture MX Q1 2026 Earnings Strong EPS Beat Amid Challenging Market Conditions Gossamer Bio GOSS Investors Reminded of June 1 2026 Securities Class Action Deadline GEL Q1 2026 Earnings EPS Misses Estimates Sharply Units Decline Medicus Pharma Ltd MDCX Edges Higher Testing Key Resistance at 032